Neo Performance Materials Inc.

Neo reported Q2 revenue of $206 million, nearly 80% higher than the second quarter of last year. Adjusted EBITDA reached a record $57 million, up 200%+ year over year, and adjusted EPS was $0.55 versus $0.21 a year ago. By segment, Magnequench revenue was $64.3 million and adjusted EBITDA was $10.5 million; Chemicals and Oxides revenue was $37.4 million and adjusted EBITDA was $8.5 million; Rare Metals revenue was $106 million and adjusted EBITDA was $44 million. The company ended the quarter with $96 million in cash and $157 million in total debt. In July, Neo raised full-year 2026 adjusted EBITDA guidance to $140 million to $150 million from $100 million to $110 million, and management said it expects to land at the high end, with possible upside.

Rahim Suleman described the quarter as “record breaking” and said execution across all business units, pricing, and volumes all remained strong. He emphasized that Neo is increasing contracted volumes through 2026 and into 2027, while also building inventory in strategic materials like hafnium, gallium, and tantalum. Strategically, he framed the company as a global rare earth magnet and critical materials supplier with two main growth vectors: the European permanent magnet facility and the bonded magnet business.

Jonathan Baksh focused on the financial momentum and balance sheet. He highlighted the record $57 million of adjusted EBITDA, the 200% year-over-year increase, and the strong segment-level results, including Rare Metals’ $44 million of EBITDA. He said the company ended with $96 million of cash and $157 million of debt, and explained that inventory rose due to deliberate hafnium scrap purchases and the ramp of the European sintered magnet business. On guidance, he tied the raised full-year outlook to strong first-half execution, higher-than-expected pricing, secured contracted volumes, and additional opportunities in spot sales.

Analysts pressed management on why the company was only guiding to the high end of the range after such a strong first half. Management said second-half guidance assumes minimal spot sales in Rare Metals, which they described as a measured, conservative assumption rather than a sign of demand weakness. They also said 2027 contracting is underway at accretive prices and that second-half spot sales could create upside. Other questions centered on bonded magnet capacity, Europe competition, and inventory costs; management said bonded magnets are an underappreciated growth area, that Neo is the only bonded magnetic powder producer at scale outside China, and that inventory costs are higher but ASPs are also higher.